FindTrial
Sign In

Development of a Standardized Culture Platform for Hepatopancreatobiliary Tumor Organoids and Exploration of Its Clinical Translational Potential

Development of a Standardized Culture Platform for Hepatopancreatobiliary Tumor Organoids and Exploration of Its Clinical Translational Potential

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114807
Enrollment
Unknown
Registered
2025-12-17
Start date
2025-06-16
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma, cholangiocarcinoma, and pancreatic cancer

Interventions

pancreatic cancer:Surgery
cholangiocarcinoma:Surgery
hepatocellular carcinoma:Surgery

Sponsors

Chongqing General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients definitively diagnosed with hepatopancreatobiliary malignancies;

Exclusion criteria

Exclusion criteria: 1.Exclusion criterion: prior preoperative chemotherapy;

Design outcomes

Primary

MeasureTime frame
Assessment of organoid culture success;—

Countries

China

Contacts

Public ContactMei Gao

Chongqing General Hospital

gaomei@cqu.edu.cn+86 23 63390054

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026